|
Volumn 118, Issue 4 PART 1, 1991, Pages 546-554
|
Neonatal screening for sickle cell disease: A cost-effectiveness analysis
a,b,c,d a,b,c,d a,b,c,d a,b,c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
PENICILLIN G;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
ETHNIC DIFFERENCE;
HUMAN;
INFECTION PREVENTION;
NEWBORN;
NEWBORN SCREENING;
PREVENTION;
PRIORITY JOURNAL;
SICKLE CELL ANEMIA;
STREPTOCOCCUS PNEUMONIAE;
ANAPHYLAXIS;
ANEMIA, SICKLE CELL;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
DRUG HYPERSENSITIVITY;
ERYTHROMYCIN;
HEMOGLOBIN SC DISEASE;
HEMOGLOBIN, SICKLE;
HUMAN;
INFANT, NEWBORN;
NEONATAL SCREENING;
PENICILLINS;
PNEUMOCOCCAL INFECTIONS;
RACIAL STOCKS;
SENSITIVITY AND SPECIFICITY;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
SUPPORT, U.S. GOV'T, P.H.S.;
TEXAS;
|
EID: 0025727755
PISSN: 00223476
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-3476(05)83375-X Document Type: Article |
Times cited : (61)
|
References (41)
|